Comparison of the prognostic value of peak creatine kinase-mb and troponin levels among patients with acute myocardial infarction: A report from the acute coronary treatment and intervention outcomes network registry-get with the guidelines

Chee Tang Chin, Tracy Y. Wang, Shuang Li, Stephen D. Wiviott, James A de Lemos, Michael C. Kontos, Eric D. Peterson, Matthew T. Roe

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Although peak creatine kinase-myocardial band (CK-MB) and troponin levels have been correlated with mortality among patients with acute myocardial infarction (AMI), the independent prognostic implications of these markers have not been compared. Hypothesis: We hypothesized that in patients with AMI, peak troponin levels (as compared to peak CK-MB levels) would have greater prognostic value. Methods: We examined AMI patients in the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) with CK-MB and troponin I levels recorded, excluding patients who were transferred in or out. Peak marker levels, standardized by the local laboratory upper limit of normal and assay standard deviation, were fitted into the previously validated ACTION Registry-GWTG mortality model to compare prognostic value. Results: Between January 2007 and March 2009, 16 009 ST-segment elevation myocardial infarction (STEMI) and 26854 non-ST-segment elevation myocardial infarction (NSTEMI) patients were identified. Peak marker ratios were directly associated with in-hospital mortality in both STEMI and NSTEMI patients. Peak CK-MB had slightly greater discrimination compared with peak troponin I in predicting mortality in both STEMI (model C-statistic 0.881 vs 0.877, P = 0.011) and NSTEMI (C-statistic 0.831 vs 0.824, P = 0.001) patients. Conclusions: Both peak CK-MB and peak troponin I levels are independently associated with in-hospital mortality in this large contemporary database of AMI patients treated in routine practice. Peak marker values slightly improved model performance in prognosticating in-hospital mortality; the incremental value was higher with CK-MB than with troponin I. These findings may help to guide future risk stratification algorithms and contribute to more efficient use of serial cardiac marker measurements in clinical practice.

Original languageEnglish (US)
Pages (from-to)424-429
Number of pages6
JournalClinical Cardiology
Volume35
Issue number7
DOIs
StatePublished - 2012

Fingerprint

Troponin
Creatine Kinase
MB Form Creatine Kinase
Registries
Myocardial Infarction
Guidelines
Troponin I
Hospital Mortality
Mortality
Databases

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparison of the prognostic value of peak creatine kinase-mb and troponin levels among patients with acute myocardial infarction : A report from the acute coronary treatment and intervention outcomes network registry-get with the guidelines. / Chin, Chee Tang; Wang, Tracy Y.; Li, Shuang; Wiviott, Stephen D.; de Lemos, James A; Kontos, Michael C.; Peterson, Eric D.; Roe, Matthew T.

In: Clinical Cardiology, Vol. 35, No. 7, 2012, p. 424-429.

Research output: Contribution to journalArticle

@article{b170eb7f764644f4a068a305a7eb981b,
title = "Comparison of the prognostic value of peak creatine kinase-mb and troponin levels among patients with acute myocardial infarction: A report from the acute coronary treatment and intervention outcomes network registry-get with the guidelines",
abstract = "Background: Although peak creatine kinase-myocardial band (CK-MB) and troponin levels have been correlated with mortality among patients with acute myocardial infarction (AMI), the independent prognostic implications of these markers have not been compared. Hypothesis: We hypothesized that in patients with AMI, peak troponin levels (as compared to peak CK-MB levels) would have greater prognostic value. Methods: We examined AMI patients in the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) with CK-MB and troponin I levels recorded, excluding patients who were transferred in or out. Peak marker levels, standardized by the local laboratory upper limit of normal and assay standard deviation, were fitted into the previously validated ACTION Registry-GWTG mortality model to compare prognostic value. Results: Between January 2007 and March 2009, 16 009 ST-segment elevation myocardial infarction (STEMI) and 26854 non-ST-segment elevation myocardial infarction (NSTEMI) patients were identified. Peak marker ratios were directly associated with in-hospital mortality in both STEMI and NSTEMI patients. Peak CK-MB had slightly greater discrimination compared with peak troponin I in predicting mortality in both STEMI (model C-statistic 0.881 vs 0.877, P = 0.011) and NSTEMI (C-statistic 0.831 vs 0.824, P = 0.001) patients. Conclusions: Both peak CK-MB and peak troponin I levels are independently associated with in-hospital mortality in this large contemporary database of AMI patients treated in routine practice. Peak marker values slightly improved model performance in prognosticating in-hospital mortality; the incremental value was higher with CK-MB than with troponin I. These findings may help to guide future risk stratification algorithms and contribute to more efficient use of serial cardiac marker measurements in clinical practice.",
author = "Chin, {Chee Tang} and Wang, {Tracy Y.} and Shuang Li and Wiviott, {Stephen D.} and {de Lemos}, {James A} and Kontos, {Michael C.} and Peterson, {Eric D.} and Roe, {Matthew T.}",
year = "2012",
doi = "10.1002/clc.21980",
language = "English (US)",
volume = "35",
pages = "424--429",
journal = "Clinical Cardiology",
issn = "0160-9289",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Comparison of the prognostic value of peak creatine kinase-mb and troponin levels among patients with acute myocardial infarction

T2 - A report from the acute coronary treatment and intervention outcomes network registry-get with the guidelines

AU - Chin, Chee Tang

AU - Wang, Tracy Y.

AU - Li, Shuang

AU - Wiviott, Stephen D.

AU - de Lemos, James A

AU - Kontos, Michael C.

AU - Peterson, Eric D.

AU - Roe, Matthew T.

PY - 2012

Y1 - 2012

N2 - Background: Although peak creatine kinase-myocardial band (CK-MB) and troponin levels have been correlated with mortality among patients with acute myocardial infarction (AMI), the independent prognostic implications of these markers have not been compared. Hypothesis: We hypothesized that in patients with AMI, peak troponin levels (as compared to peak CK-MB levels) would have greater prognostic value. Methods: We examined AMI patients in the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) with CK-MB and troponin I levels recorded, excluding patients who were transferred in or out. Peak marker levels, standardized by the local laboratory upper limit of normal and assay standard deviation, were fitted into the previously validated ACTION Registry-GWTG mortality model to compare prognostic value. Results: Between January 2007 and March 2009, 16 009 ST-segment elevation myocardial infarction (STEMI) and 26854 non-ST-segment elevation myocardial infarction (NSTEMI) patients were identified. Peak marker ratios were directly associated with in-hospital mortality in both STEMI and NSTEMI patients. Peak CK-MB had slightly greater discrimination compared with peak troponin I in predicting mortality in both STEMI (model C-statistic 0.881 vs 0.877, P = 0.011) and NSTEMI (C-statistic 0.831 vs 0.824, P = 0.001) patients. Conclusions: Both peak CK-MB and peak troponin I levels are independently associated with in-hospital mortality in this large contemporary database of AMI patients treated in routine practice. Peak marker values slightly improved model performance in prognosticating in-hospital mortality; the incremental value was higher with CK-MB than with troponin I. These findings may help to guide future risk stratification algorithms and contribute to more efficient use of serial cardiac marker measurements in clinical practice.

AB - Background: Although peak creatine kinase-myocardial band (CK-MB) and troponin levels have been correlated with mortality among patients with acute myocardial infarction (AMI), the independent prognostic implications of these markers have not been compared. Hypothesis: We hypothesized that in patients with AMI, peak troponin levels (as compared to peak CK-MB levels) would have greater prognostic value. Methods: We examined AMI patients in the National Cardiovascular Data Registry ACTION Registry-GWTG (Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines) with CK-MB and troponin I levels recorded, excluding patients who were transferred in or out. Peak marker levels, standardized by the local laboratory upper limit of normal and assay standard deviation, were fitted into the previously validated ACTION Registry-GWTG mortality model to compare prognostic value. Results: Between January 2007 and March 2009, 16 009 ST-segment elevation myocardial infarction (STEMI) and 26854 non-ST-segment elevation myocardial infarction (NSTEMI) patients were identified. Peak marker ratios were directly associated with in-hospital mortality in both STEMI and NSTEMI patients. Peak CK-MB had slightly greater discrimination compared with peak troponin I in predicting mortality in both STEMI (model C-statistic 0.881 vs 0.877, P = 0.011) and NSTEMI (C-statistic 0.831 vs 0.824, P = 0.001) patients. Conclusions: Both peak CK-MB and peak troponin I levels are independently associated with in-hospital mortality in this large contemporary database of AMI patients treated in routine practice. Peak marker values slightly improved model performance in prognosticating in-hospital mortality; the incremental value was higher with CK-MB than with troponin I. These findings may help to guide future risk stratification algorithms and contribute to more efficient use of serial cardiac marker measurements in clinical practice.

UR - http://www.scopus.com/inward/record.url?scp=84863442247&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863442247&partnerID=8YFLogxK

U2 - 10.1002/clc.21980

DO - 10.1002/clc.21980

M3 - Article

C2 - 22434769

AN - SCOPUS:84863442247

VL - 35

SP - 424

EP - 429

JO - Clinical Cardiology

JF - Clinical Cardiology

SN - 0160-9289

IS - 7

ER -